Molecular basis of multidrug transport by ABC transporters

Markus A Seeger1, Hendrik W van Veen

  • 1Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge CB2 1PD, United Kingdom.

Insights

Multidrug ABC transporters like P-glycoprotein (ABCB1) are key to drug resistance. This review explores how ATP hydrolysis in nucleotide-binding domains (NBDs) links to substrate release in membrane domains (MDs).

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Multidrug ABC transporters, including P-glycoprotein (ABCB1), mediate drug efflux, contributing to chemotherapy failure.
  • These transporters comprise nucleotide-binding domains (NBDs) for ATP binding/hydrolysis and membrane domains (MDs) for substrate transport.
  • Overexpression of these transporters is a significant challenge in anticancer and antimicrobial therapies.

Purpose of the Study:

  • To review current evidence on transport models for multidrug ABC transporters.
  • To elucidate the structure-function relationships governing drug binding and release.
  • To reconcile conflicting views on the mechanism linking ATP hydrolysis to substrate transport.

Main Methods:

  • Analysis of recent crystal structures of bacterial ABCB1 homologues (e.g., Sav1866, MsbA).
  • Integration of structural data with existing cellular and biochemical findings.
  • Comparative analysis of different proposed transport models.

Main Results:

  • Recent structural data provide insights into the conformational states of multidrug ABC transporters.
  • Structural information aids in interpreting decades of biochemical and cellular data.
  • Contradictory views exist regarding the coupling of ATP hydrolysis to substrate affinity changes.

Conclusions:

  • Understanding the dynamic interplay between NBDs and MDs is crucial for deciphering transporter function.
  • Structure-function relationships are key to understanding multidrug resistance mechanisms.
  • Further research is needed to fully resolve the catalytic cycle and its link to drug transport.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...